# Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

> **NCT00443820** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 526 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** terbinafine
- **DRUG:** Placebo
- **DRUG:** terbinafine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00443820
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 526 (ACTUAL)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443820, "Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00443820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*